|
1
|
Sousa CM and Kimmelman AC: The complex
landscape of pancreatic cancer metabolism. Carcinogenesis.
35:1441–1450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McCarroll JA, Naim S, Sharbeen G, Russia
N, Lee J, Kavallaris M, Goldstein D and Phillips PA: Role of
pancreatic stellate cells in chemoresistance in pancreatic cancer.
Front Physiol. 5:1412014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suzuki T, Nakayama H and Yamaguchi M:
Effect of wasabi leafstalk (Wasabia japonica Matsum) extract on
bone metabolism in mouse calvaria tissue culture. Food Sci Technol
Int Tokyo. 3:366–369. 1997. View Article : Google Scholar
|
|
5
|
Suzuki T and Yamaguchi M: Purification of
active component in wasabi leafstalk (Wasabia japonica Matsum)
extract in stimulating bone calcification in vitro. J Health Sci.
50:483–490. 2004. View Article : Google Scholar
|
|
6
|
Lai YL and Yamaguchi M: Phytocomponent
p-hydroxycinnamic acid stimulates bone formation and inhibits bone
resorption in rat femoral tissues in vitro. Mol Cell Biochem.
292:45–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamaguchi M, Lai YL, Uchiyama S and
Nakagawa T: Oral administration of phytocomponent p-hydroxycinnamic
acid prevents bone loss in ovariectomized rats. Mol Cell Biochem.
311:31–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamaguchi M, Uchiyama S and Lai YL: Oral
administration of phytocomponent p-hydroxycinnamic acid has a
preventive effect on bone loss in streptozotocin-induced diabetic
rats. Int J Mol Med. 19:803–807. 2007.PubMed/NCBI
|
|
9
|
Lai YL and Yamaguchi M: Phytocomponent
p-hydroxycinnamic acid inhibits osteoclast-like cell formation in
mouse bone marrow cultures. Int J Mol Med. 19:123–128. 2007.
|
|
10
|
Yamaguchi M, Lai YL, Uchiyama S and
Nakagawa T: Phytocomponent p-hydroxycinnamic acid stimulates
mineralization in osteoblastic MC3T3-E1 cells. Int J Mol Med.
22:287–291. 2008.PubMed/NCBI
|
|
11
|
Yamaguchi M and Weitzmann MN: The bone
anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast
mineralization and suppresses osteoclast differentiation by
antagonizing NF-κB activation. Int J Mol Med. 30:708–712.
2012.PubMed/NCBI
|
|
12
|
Yamaguchi M, Baile CA, Zhu S and Shoji M:
Bioactive flavonoid p-hydroxycinnamic acid stimulates
osteoblastogenesis and suppresses adipogenesis in bone marrow
culture. Cell Tissue Res. 354:743–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ninomiya I, Yamazaki K, Oyama K, Hayashi
H, Tajima H, Kitagawa H, Fushida S, Fujimura T and Ohta T:
Pioglitazone inhibits the proliferation and metastasis of human
pancreatic cancer cells. Oncol Lett. 8:2709–2714. 2014.PubMed/NCBI
|
|
14
|
Sipos B, Möser S, Kalthoff H, Török V,
Löhr M and Klöppel G: A comprehensive characterization of
pancreatic ductal carcinoma cell lines: Towards the establishment
of an in vitro reseach platform. Virchows Arch. 442:444–452.
2003.PubMed/NCBI
|
|
15
|
Misawa H, Inagaki S and Yamaguchi M:
Suppression of cell proliferation and deoxyribonucleic acid
synthesis in the cloned rat hepatoma H4-II-E cells overexpressing
regucalcin. J Cell Biochem. 84:143–149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamaguchi M and Daimon Y: Overexpression
of regucalcin suppresses cell proliferation in cloned rat hepatoma
H4-II-E cells: Involvement of intracellular signaling factors and
cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaguchi M: The anti-apoptotic effect of
regucalcin is mediated through multisignaling pathways. Apoptosis.
18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamaguchi M, Zhu S, Weitzmann MN, Snyder
JP and Shoji M: Curcumin analog UBS109 prevents bone marrow
osteoblastogenesis and osteoclastogenesis disordered by coculture
with breast cancer MDA-MB-231 bone metastatic cells in vitro. Mol
Cell Biochem. 401:1–10. 2015. View Article : Google Scholar
|
|
19
|
Meijer L, Borgne A, Mulner O, Chong JP,
Blow JJ, Inagaki N, Inagaki M, Delcros JG and Moulinoux JP:
Biochemical and cellular effects of roscovitine, a potent and
selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and
cdk5. Eur J Biochem. 243:527–536. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singh SV, Herman-Antosiewicz A, Singh AV,
Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L and Baskaran R:
Sulforaphane-induced G2/M phase cell cycle arrest involves
checkpoint kinase 2-mediated phosphorylation of cell division cycle
25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Li A, Strait K, Zhang H, Nanes MS
and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass
and inhibits osteoblastic Smad activation through NF-kappaB. J Bone
Miner Res. 22:646–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cano-Abad MF, Villarroya M, García AG,
Gabilan NH and López MG: Calcium entry through L-type calcium
channels causes mitochondrial disruption and chromaffin cell death.
J Biol Chem. 276:39695–39704. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S, Wang Y, Ruan W, Wang X and Pan C:
Reversing multidrug resistance in hepatocellular carcinoma cells by
inhibiting extracellular signal-regulated kinase/mitogen-activated
protein kinase signaling pathway activity. Oncol Lett. 8:2333–2339.
2014.PubMed/NCBI
|
|
24
|
Chen QW, Edvinsson L and Xu CB: Role of
ERK/MAPK in endothelin receptor signaling in human aortic smooth
muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Serrano-Nascimento C, da Silva Teixeira S,
Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute
inhibitory effect of iodide excess on sodium/iodide symporter
expression and activity involves the PI3K/Akt signaling pathway.
Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Palangat M, Grass JA, Langelier MF,
Coulombe B and Landick R: The RPB2 flap loop of human RNA
polymerase II is dispensable for transcription initiation and
elongation. Mol Cell Biol. 31:3312–3325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang SC and Chen YC: Novel therapeutic
targets for pancreatic cancer. World J Gastroenterol.
20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
|
